Kutatási jelek – Signal Engine

Successes and challenges in the treatment of pediatric acute myeloid leukemia: a retrospective analysis of the AML-BFM trials from 1987 to 2012 — Acute myeloid leukemia
Adjuvant chemoradiotherapy versus radiotherapy alone for women with high‑risk endometrial cancer (PORTEC‑3): final results of an international, open‑label, multicentre, randomised, phase 3 trial — Endometrial cancer
Systemic Treatment of Metastatic/Recurrent Uterine Leiomyosarcoma: A Changing Paradigm — Gastrointestinal stromal tumor
An update on gastrointestinal stromal tumors (GISTs) with a focus on extragastrointestinal stromal tumors (EGISTs) — Colorectal cancer
Novel therapies for malignant pleural mesothelioma — Malignant pleural mesothelioma
Updates in Diagnosis, Management, and Treatment of Neuroblastoma — Neuroblastoma
On the architecture of translational research designed to control chronic lymphocytic leukemia — Chronic lymphocytic leukemia
The biology and treatment of Merkel cell carcinoma: current understanding and research priorities — Merkel cell carcinoma
Cytogenetics and gene mutations influence survival in older patients with acute myeloid leukemia treated with azacitidine or conventional care — Lymphoma
Sunitinib Alone or after Nephrectomy in Metastatic Renal‑Cell Carcinoma — Renal cell carcinoma
Modified FOLFIRINOX improves survival compared to gemcitabine in resected pancreatic cancer — Pancreatic cancer
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial — Hepatocellular carcinoma
Apalutamide Treatment and Metastasis‑free Survival in Prostate Cancer — Prostate cancer
Effect of a Low-Intensity PSA-Based Screening Intervention on Prostate Cancer Mortality — Prostate cancer
Short‑term versus intermediate‑term androgen suppression plus radiotherapy with or without zoledronic acid in men with locally advanced prostate cancer: 10‑year results from the RADAR trial — Prostate cancer
Adjuvant Chemotherapy Guided by a 21‑Gene Expression Assay in Breast Cancer — Breast cancer
Duration of Adjuvant Chemotherapy for Stage III Colon Cancer — Colorectal cancer
Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal Cancer — Colorectal cancer
Pembrolizumab plus Chemotherapy for Squamous Non‑Small‑Cell Lung Cancer — NSCLC
Pancreatic Cancer — Pancreatic cancer